Health and Fitness Health and Fitness
Mon, August 29, 2011
[ 04:00 AM ] - Market Wire
Media Statement from Amedisys Chief Medical Offic .. Study aChallenges in Posthospital Care: Nurses As
[ 12:20 AM ] - Market Wire
QIAGEN Completes Acquisition of Cellestis Limited
[ 12:20 AM ] - Market Wire
Cord Blood America Enters Agreement With BancoVid .. Blood Collection Company in San Juan, Puerto Rico
Fri, August 26, 2011
[ 04:00 PM ] - Market Wire
MedCath Announces Agreement to Sell Hualapai Moun .. Medical Center to Kingman Regional Medical Center
[ 04:00 PM ] - Market Wire
Gentiva® Health Services Agrees to Sell Remaining Equity Stake in CareCentrix
[ 04:00 PM ] - Market Wire
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
[ 02:13 PM ] - Market Wire
Allegiance Equity Corporation Announces Private Placement
[ 02:10 PM ] - Market Wire
Sonomax Reports Second Quarter 2011 Results
[ 01:00 PM ] - Market Wire
Medwell Announces Shareholder Approval of Plan of Arrangement
[ 12:28 PM ] - Market Wire
FDA Approves Dendreon's Atlanta Cancer Immunotherapy Manufacturing Facility
[ 09:50 AM ] - Market Wire
Award-Winning Actress Blythe Danner and Amgen Lau .. h Act 2 Reduce Fractures(TM) Educational Campaign
[ 08:00 AM ] - Market Wire
New Study from Humana and Wisconsin Health Inform .. lan Costs Decrease When Health Information Exchan
[ 02:00 AM ] - Market Wire
Center for Proteomics at the Translational Genomi .. te (TGen) Selected as Waters Center of Innovation
[ 01:35 AM ] - Market Wire
Winner Medical to Attend Investor Conferences in September
Thu, August 25, 2011
[ 09:01 PM ] - Market Wire
Results of Emergent BioSolutions Phase 1a Study o .. Anthrax Vaccine Published in the Journal Vaccine
[ 05:00 PM ] - Market Wire
Cyberonics to Participate in 2011 Baird Healthcare Conference
[ 05:00 PM ] - Market Wire
Endo Pharmaceuticals to Present at the Stifel Nicolaus Annual Healthcare Conference
[ 05:00 PM ] - Market Wire
SyntheMed, Inc. Announces Stockholder Approval of Planned Merger With Pathfinder, LLC
[ 04:40 PM ] - Market Wire
USANA is Now an Official Partner of the U.S. Ski Team, U.S. Snowboarding, and U.S. Freeskiing
[ 04:40 PM ] - Market Wire
Accuray Incorporated to Host Investor Meeting at ASTRO 2011
[ 01:32 PM ] - Market Wire
Inhibitex to Present at Two Upcoming Conferences
[ 11:00 AM ] - Market Wire
Cambridge Heart Launches Enhanced Website
[ 10:21 AM ] - Market Wire
Diana Moore Appointed as Director, Investor Relat .. siness Development at Advaxis, Conrad Mir Departs
[ 09:30 AM ] - Market Wire
Humana Announces Agreement to Acquire Arcadian Management Services
[ 08:29 AM ] - Market Wire
Gallup and Healthways Release July 2011 Well-Being Index
[ 07:18 AM ] - Market Wire
Trajenta® (linagliptin) Receives Approval for the Treatment of Type 2 Diabetes in Europe
[ 06:00 AM ] - Market Wire
LabCorp Introduces HCV Resistance Testing through .. sciences with the Launch of HCV GenoSure® NS3/4A
[ 05:00 AM ] - Market Wire
Hi-Tech Pharmacal Acquires Rights to TussiCaps® .. e Promoted by Their ECR Pharmaceuticals Subsidiar
[ 05:00 AM ] - Market Wire
Zynex Enters into Letter of Intent with NeuroDyne Medical, Corp.
[ 05:00 AM ] - Market Wire
Fibrocell Science, Inc. to Present at the Kaufman Bros. 14th Annual Investor Conference

Fibrocell Science, Inc. to Present at the Kaufman Bros. 14th Annual Investor Conference


Published on 2011-08-25 05:10:59 - Market Wire
  Print publication without navigation


EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Companya™s Chairman and CEO, will be presenting at the Kaufman Bros. 14th Annual Investor Conference to be held on September 7-8, 2011 at the W Hotel New York.

Fibrocella™s presentation is scheduled for Wednesday, September 7, at 12:00 p.m. Eastern Time.

The presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at [ www.fibrocellscience.com ].

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].

Contributing Sources